id int64 | platform_type string | seller_id string | platform_name string | product_name string | product_category string | prescription_required_legally int64 | prescription_verified int64 | product_registered int64 | seller_licensed int64 | pharmacist_consultation int64 | verified_supply_chain int64 | cold_chain_maintained int64 | manufacturer_origin string | quality_test_result string | sf_classification string | API_content_adequate int64 | price_vs_reference float64 | payment_method string | consumer_age_group string | consumer_education string | consumer_complaint_filed int64 | adverse_event_reported int64 | website_takedown int64 | year int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | social_media | EPHARM_00923 | WhatsApp | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.84 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
102 | social_media | EPHARM_00582 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 1 | 0 | 0 | India | fail | substandard | 0 | 0.74 | cryptocurrency | 35_49 | primary | 0 | 0 | 0 | 2,020 |
103 | social_media | EPHARM_00864 | TikTok | opioid_analgesic | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 1 | unknown | pass | compliant | 1 | 0.71 | cash_on_delivery | 50_plus | tertiary | 0 | 0 | 0 | 2,020 |
104 | social_media | EPHARM_00224 | marketplace_app | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.46 | credit_card | 35_49 | secondary | 1 | 0 | 0 | 2,024 |
105 | social_media | EPHARM_00521 | Facebook | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.26 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
106 | social_media | EPHARM_00734 | marketplace_app | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.65 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,023 |
107 | social_media | EPHARM_00542 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 1 | India | fail | falsified | 1 | 0.71 | cash_on_delivery | 25_34 | primary | 0 | 0 | 0 | 2,021 |
108 | social_media | EPHARM_00522 | marketplace_app | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | pass | compliant | 1 | 1.14 | mobile_money | 25_34 | secondary | 1 | 0 | 0 | 2,024 |
109 | social_media | EPHARM_00190 | TikTok | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.73 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
110 | social_media | EPHARM_00017 | Instagram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | USA | fail | falsified | 0 | 0.72 | mobile_money | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
111 | social_media | EPHARM_00304 | TikTok | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 1 | China | fail | falsified | 1 | 0.71 | cryptocurrency | 50_plus | tertiary | 0 | 0 | 0 | 2,022 |
112 | social_media | EPHARM_00717 | Facebook | antimalarial | essential | 1 | 0 | 0 | 0 | 1 | 0 | 0 | India | fail | falsified | 0 | 0.71 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,020 |
113 | social_media | EPHARM_00226 | marketplace_app | cancer_medicine | specialty | 1 | 1 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.86 | mobile_money | 50_plus | primary | 0 | 0 | 0 | 2,023 |
114 | social_media | EPHARM_00202 | WhatsApp | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.8 | bank_transfer | 50_plus | secondary | 0 | 0 | 0 | 2,023 |
115 | social_media | EPHARM_00052 | Instagram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | USA | pass | compliant | 1 | 0.76 | cryptocurrency | 18_24 | secondary | 1 | 0 | 0 | 2,023 |
116 | social_media | EPHARM_00418 | Instagram | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 0 | 0.85 | mobile_money | 50_plus | tertiary | 1 | 0 | 0 | 2,024 |
117 | social_media | EPHARM_00491 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.58 | bank_transfer | 25_34 | secondary | 1 | 0 | 0 | 2,024 |
118 | social_media | EPHARM_00443 | WhatsApp | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.68 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
119 | social_media | EPHARM_00543 | Telegram | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.64 | credit_card | 35_49 | primary | 0 | 0 | 0 | 2,023 |
120 | social_media | EPHARM_00255 | WhatsApp | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | pass | compliant | 1 | 0.54 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
121 | social_media | EPHARM_00488 | Facebook | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.54 | cash_on_delivery | 25_34 | secondary | 1 | 0 | 0 | 2,020 |
122 | social_media | EPHARM_00420 | WhatsApp | antidiabetic | NCD | 1 | 1 | 1 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 1 | 0.22 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
123 | social_media | EPHARM_00824 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.95 | bank_transfer | 35_49 | primary | 0 | 0 | 0 | 2,022 |
124 | social_media | EPHARM_00496 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.55 | mobile_money | 18_24 | primary | 0 | 0 | 0 | 2,023 |
125 | social_media | EPHARM_00768 | marketplace_app | benzodiazepine | controlled | 1 | 0 | 1 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 0 | 0.78 | bank_transfer | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
126 | social_media | EPHARM_00426 | Facebook | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 1.25 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,020 |
127 | social_media | EPHARM_00306 | darknet_market | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.76 | mobile_money | 50_plus | tertiary | 0 | 0 | 0 | 2,023 |
128 | social_media | EPHARM_00595 | Facebook | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.8 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,022 |
129 | social_media | EPHARM_00921 | darknet_market | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.66 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
130 | social_media | EPHARM_00697 | dedicated_website | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 1 | 0.97 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
131 | social_media | EPHARM_00331 | Facebook | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.72 | cash_on_delivery | 35_49 | primary | 0 | 0 | 0 | 2,023 |
132 | social_media | EPHARM_00051 | WhatsApp | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 1 | 0.86 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
133 | social_media | EPHARM_00682 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.7 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
134 | social_media | EPHARM_00420 | dedicated_website | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 1 | Europe | pass | compliant | 1 | 0.87 | mobile_money | 18_24 | secondary | 0 | 0 | 0 | 2,021 |
135 | social_media | EPHARM_00615 | Instagram | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 1 | India | pass | compliant | 1 | 0.8 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
136 | social_media | EPHARM_00320 | WhatsApp | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 1 | 0 | 0 | unknown | fail | substandard | 1 | 1.06 | mobile_money | 50_plus | primary | 0 | 0 | 0 | 2,020 |
137 | social_media | EPHARM_00602 | Instagram | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.82 | credit_card | 50_plus | secondary | 0 | 0 | 0 | 2,020 |
138 | social_media | EPHARM_00445 | Facebook | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.99 | cryptocurrency | 50_plus | tertiary | 0 | 0 | 0 | 2,023 |
139 | social_media | EPHARM_00150 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.97 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
140 | social_media | EPHARM_00423 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.32 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
141 | social_media | EPHARM_00563 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.7 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
142 | social_media | EPHARM_00806 | Facebook | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.94 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
143 | social_media | EPHARM_00560 | TikTok | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.7 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
144 | social_media | EPHARM_00709 | Facebook | contraceptive | reproductive | 0 | 0 | 1 | 0 | 0 | 0 | 1 | India | pass | compliant | 1 | 0.99 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
145 | social_media | EPHARM_00989 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 0.44 | mobile_money | 50_plus | tertiary | 0 | 0 | 0 | 2,023 |
146 | social_media | EPHARM_00094 | dedicated_website | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.68 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,022 |
147 | social_media | EPHARM_00528 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 0.67 | cryptocurrency | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
148 | social_media | EPHARM_00136 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 1 | 0 | India | fail | falsified | 1 | 0.91 | mobile_money | 18_24 | tertiary | 0 | 1 | 0 | 2,023 |
149 | social_media | EPHARM_00521 | dedicated_website | opioid_analgesic | controlled | 1 | 1 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.34 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
150 | social_media | EPHARM_00283 | Instagram | opioid_analgesic | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 1 | 0.7 | bank_transfer | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
151 | social_media | EPHARM_00957 | marketplace_app | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 1.05 | bank_transfer | 18_24 | secondary | 1 | 0 | 0 | 2,023 |
152 | social_media | EPHARM_00432 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.7 | mobile_money | 50_plus | tertiary | 0 | 0 | 0 | 2,024 |
153 | social_media | EPHARM_00404 | dedicated_website | opioid_analgesic | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | USA | fail | substandard | 0 | 0.49 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
154 | social_media | EPHARM_00204 | WhatsApp | antidiabetic | NCD | 1 | 1 | 0 | 0 | 0 | 1 | 0 | unknown | fail | falsified | 1 | 0.45 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,021 |
155 | social_media | EPHARM_00914 | WhatsApp | cancer_medicine | specialty | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.7 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,022 |
156 | social_media | EPHARM_00245 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 0 | 0.59 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,023 |
157 | social_media | EPHARM_00401 | dedicated_website | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.74 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
158 | social_media | EPHARM_00819 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 1.03 | mobile_money | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
159 | social_media | EPHARM_00876 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | falsified | 0 | 1.09 | cash_on_delivery | 25_34 | tertiary | 1 | 0 | 0 | 2,024 |
160 | social_media | EPHARM_00709 | dedicated_website | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.43 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,021 |
161 | social_media | EPHARM_00825 | marketplace_app | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.6 | bank_transfer | 18_24 | tertiary | 0 | 1 | 0 | 2,024 |
162 | social_media | EPHARM_00648 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.72 | mobile_money | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
163 | social_media | EPHARM_00178 | darknet_market | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.75 | cash_on_delivery | 35_49 | secondary | 0 | 0 | 0 | 2,024 |
164 | social_media | EPHARM_00850 | Instagram | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.88 | bank_transfer | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
165 | social_media | EPHARM_00125 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 1.12 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,021 |
166 | social_media | EPHARM_00427 | WhatsApp | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 1 | 0.73 | cash_on_delivery | 35_49 | tertiary | 1 | 0 | 0 | 2,023 |
167 | social_media | EPHARM_00298 | dedicated_website | antidiabetic | NCD | 1 | 1 | 1 | 0 | 0 | 0 | 1 | Europe | pass | compliant | 1 | 0.73 | bank_transfer | 18_24 | primary | 1 | 0 | 0 | 2,024 |
168 | social_media | EPHARM_00986 | Facebook | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | falsified | 1 | 0.69 | credit_card | 50_plus | tertiary | 0 | 0 | 1 | 2,020 |
169 | social_media | EPHARM_00212 | WhatsApp | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.87 | cash_on_delivery | 35_49 | primary | 0 | 0 | 0 | 2,023 |
170 | social_media | EPHARM_00110 | dedicated_website | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 0.52 | credit_card | 25_34 | primary | 0 | 0 | 0 | 2,024 |
171 | social_media | EPHARM_00302 | darknet_market | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | falsified | 1 | 0.56 | bank_transfer | 25_34 | secondary | 1 | 0 | 0 | 2,021 |
172 | social_media | EPHARM_00473 | darknet_market | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.76 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
173 | social_media | EPHARM_00463 | dedicated_website | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.52 | mobile_money | 50_plus | tertiary | 1 | 0 | 0 | 2,020 |
174 | social_media | EPHARM_00353 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.92 | mobile_money | 25_34 | primary | 0 | 0 | 0 | 2,024 |
175 | social_media | EPHARM_00550 | marketplace_app | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 1 | India | fail | falsified | 0 | 0.72 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
176 | social_media | EPHARM_00604 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 1 | 0 | India | fail | substandard | 0 | 0.62 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
177 | social_media | EPHARM_00126 | Instagram | antidiabetic | NCD | 1 | 0 | 0 | 0 | 0 | 1 | 0 | India | pass | compliant | 1 | 0.61 | mobile_money | 50_plus | secondary | 0 | 0 | 0 | 2,024 |
178 | social_media | EPHARM_00315 | darknet_market | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.87 | mobile_money | 35_49 | tertiary | 1 | 0 | 0 | 2,024 |
179 | social_media | EPHARM_00478 | WhatsApp | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 0.71 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,020 |
180 | social_media | EPHARM_00648 | marketplace_app | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.78 | cryptocurrency | 25_34 | tertiary | 0 | 0 | 0 | 2,020 |
181 | social_media | EPHARM_00151 | Instagram | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 1 | 0.65 | cryptocurrency | 35_49 | tertiary | 1 | 1 | 0 | 2,024 |
182 | social_media | EPHARM_00562 | darknet_market | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 1 | India | pass | compliant | 1 | 0.6 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
183 | social_media | EPHARM_00793 | Telegram | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.45 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
184 | social_media | EPHARM_00552 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.95 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
185 | social_media | EPHARM_00464 | darknet_market | antidiabetic | NCD | 1 | 1 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 0.64 | credit_card | 18_24 | secondary | 0 | 0 | 0 | 2,021 |
186 | social_media | EPHARM_00278 | Facebook | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 1 | 0 | 0 | unknown | fail | falsified | 0 | 0.75 | mobile_money | 50_plus | secondary | 0 | 0 | 0 | 2,023 |
187 | social_media | EPHARM_00422 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.44 | credit_card | 35_49 | secondary | 0 | 0 | 0 | 2,024 |
188 | social_media | EPHARM_00480 | Facebook | cancer_medicine | specialty | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.75 | cryptocurrency | 25_34 | tertiary | 1 | 0 | 0 | 2,023 |
189 | social_media | EPHARM_00589 | darknet_market | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.42 | mobile_money | 50_plus | tertiary | 0 | 0 | 0 | 2,023 |
190 | social_media | EPHARM_00722 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | India | fail | falsified | 1 | 0.44 | cash_on_delivery | 50_plus | tertiary | 0 | 0 | 0 | 2,022 |
191 | social_media | EPHARM_00285 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 1 | 0.55 | bank_transfer | 25_34 | primary | 0 | 0 | 0 | 2,023 |
192 | social_media | EPHARM_00964 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.46 | mobile_money | 18_24 | secondary | 1 | 0 | 0 | 2,024 |
193 | social_media | EPHARM_00536 | Facebook | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.5 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
194 | social_media | EPHARM_00058 | WhatsApp | contraceptive | reproductive | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.99 | bank_transfer | 18_24 | tertiary | 1 | 0 | 0 | 2,024 |
195 | social_media | EPHARM_00990 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.77 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
196 | social_media | EPHARM_00424 | marketplace_app | contraceptive | reproductive | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.43 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
197 | social_media | EPHARM_00903 | darknet_market | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.7 | mobile_money | 18_24 | primary | 0 | 0 | 0 | 2,023 |
198 | social_media | EPHARM_00168 | Instagram | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.57 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
199 | social_media | EPHARM_00355 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.69 | mobile_money | 35_49 | secondary | 0 | 1 | 0 | 2,023 |
200 | social_media | EPHARM_00491 | dedicated_website | antihypertensive | NCD | 1 | 0 | 0 | 0 | 1 | 0 | 0 | India | fail | falsified | 1 | 0.71 | credit_card | 35_49 | tertiary | 1 | 0 | 0 | 2,023 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.